CR9108A - Prevencion de infecciones endoparasitas verticales - Google Patents

Prevencion de infecciones endoparasitas verticales

Info

Publication number
CR9108A
CR9108A CR9108A CR9108A CR9108A CR 9108 A CR9108 A CR 9108A CR 9108 A CR9108 A CR 9108A CR 9108 A CR9108 A CR 9108A CR 9108 A CR9108 A CR 9108A
Authority
CR
Costa Rica
Prior art keywords
endoparasites
prevention
vertical
infections
andoparasiticide
Prior art date
Application number
CR9108A
Other languages
English (en)
Inventor
Bach Thomas
Tanzler Janina
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of CR9108A publication Critical patent/CR9108A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere al uso de depsipeptidos andoparasiticidas para la preparacion de medicamentos para la prevencion de infeccion vertical con endoparasitos
CR9108A 2004-11-16 2007-05-09 Prevencion de infecciones endoparasitas verticales CR9108A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004055316A DE102004055316A1 (de) 2004-11-16 2004-11-16 Verhinderung vertikaler Endoparasiten-Infektionen

Publications (1)

Publication Number Publication Date
CR9108A true CR9108A (es) 2007-09-11

Family

ID=35767587

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9108A CR9108A (es) 2004-11-16 2007-05-09 Prevencion de infecciones endoparasitas verticales

Country Status (30)

Country Link
US (1) US20090215678A1 (es)
EP (1) EP1814572B1 (es)
JP (1) JP5078619B2 (es)
KR (1) KR101280511B1 (es)
CN (1) CN101102785B (es)
AR (1) AR052133A1 (es)
AT (1) ATE469652T1 (es)
AU (1) AU2005306070B2 (es)
BR (1) BRPI0518172A (es)
CA (1) CA2587537C (es)
CR (1) CR9108A (es)
DE (2) DE102004055316A1 (es)
DK (1) DK1814572T3 (es)
ES (1) ES2345265T3 (es)
HK (1) HK1117041A1 (es)
HR (1) HRP20100471T1 (es)
IL (1) IL183200A (es)
MX (1) MX2007005766A (es)
MY (1) MY142727A (es)
NO (1) NO341472B1 (es)
NZ (1) NZ555117A (es)
PE (1) PE20061079A1 (es)
PL (1) PL1814572T3 (es)
PT (1) PT1814572E (es)
RU (1) RU2405565C2 (es)
SI (1) SI1814572T1 (es)
TW (1) TWI358293B (es)
UA (1) UA91694C2 (es)
WO (1) WO2006053641A1 (es)
ZA (1) ZA200703982B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
JP6185930B2 (ja) * 2011-12-21 2017-08-23 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 非晶質エモデプシド含有製剤
JP7045191B2 (ja) 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP6943859B2 (ja) 2015-12-28 2021-10-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
WO2019091975A1 (en) 2017-11-07 2019-05-16 Bayer Animal Health Gmbh Method for the synthesis of cyclic depsipeptides

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
AU669883B2 (en) * 1992-03-17 1996-06-27 Astellas Pharma Inc. Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
KR100309091B1 (ko) * 1993-02-19 2001-12-28 이치로 키타사토 환상 데프시펩티드 pf 1022의 유도체
EP0648121B1 (en) * 1993-05-05 1996-10-02 Palo Alto Medical Foundation Use of rifamycin derivatives for the manufacture of a medicament for the treatment of toxoplasmosis
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
ES2170101T3 (es) * 1993-09-06 2002-08-01 Fujisawa Pharmaceutical Co Compuesto ciclodepsipeptido.
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4401389A1 (de) * 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) * 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4437198A1 (de) * 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
DE69637876D1 (de) * 1995-06-30 2009-04-30 Astellas Pharma Inc Ng und zwischenprodukt dafür
DE69634961T2 (de) * 1995-09-22 2006-04-20 Bayer Ag Neue zyklische depsipeptid pf1022 derivate
DE19545639A1 (de) * 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
DE19962147A1 (de) * 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
GB0008353D0 (en) * 2000-04-03 2000-05-24 Pfizer Ltd Method of treating a parasitic infection
US20010036922A1 (en) * 2000-04-03 2001-11-01 Benchaoui Hafid Abdelaali Method of treating a parasitic infection
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
HRP20100471T1 (hr) 2010-10-31
UA91694C2 (ru) 2010-08-25
MY142727A (en) 2010-12-31
ZA200703982B (en) 2008-08-27
PE20061079A1 (es) 2006-11-30
IL183200A0 (en) 2007-08-19
KR101280511B1 (ko) 2013-07-01
TW200626140A (en) 2006-08-01
MX2007005766A (es) 2007-07-16
RU2007122284A (ru) 2008-12-27
PL1814572T3 (pl) 2010-11-30
ATE469652T1 (de) 2010-06-15
DK1814572T3 (da) 2010-09-20
AU2005306070A1 (en) 2006-05-26
AU2005306070B2 (en) 2011-05-12
IL183200A (en) 2011-12-29
CN101102785B (zh) 2011-05-18
EP1814572B1 (de) 2010-06-02
US20090215678A1 (en) 2009-08-27
HK1117041A1 (en) 2009-01-09
WO2006053641A1 (de) 2006-05-26
EP1814572A1 (de) 2007-08-08
KR20070084412A (ko) 2007-08-24
NZ555117A (en) 2009-11-27
AR052133A1 (es) 2007-03-07
ES2345265T3 (es) 2010-09-20
RU2405565C2 (ru) 2010-12-10
NO20073023L (no) 2007-08-10
BRPI0518172A (pt) 2008-11-04
NO341472B1 (no) 2017-11-20
CA2587537C (en) 2014-06-03
DE102004055316A1 (de) 2006-05-18
CN101102785A (zh) 2008-01-09
SI1814572T1 (sl) 2010-09-30
DE502005009697D1 (de) 2010-07-15
JP2008520598A (ja) 2008-06-19
JP5078619B2 (ja) 2012-11-21
PT1814572E (pt) 2010-08-02
CA2587537A1 (en) 2006-05-26
TWI358293B (en) 2012-02-21

Similar Documents

Publication Publication Date Title
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
BRPI0411528A (pt) uso de isomalte como prebiótico
CR9108A (es) Prevencion de infecciones endoparasitas verticales
ECSP10010722A (es) Compuestos orgánicos
CR8428A (es) Agente endoparasiticidas para la administracion topica
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
ATE528989T1 (de) Kristalline feste rasagilin-base
ECSP099044A (es) Compuestos de pirimido fusionados
HN2004000490A (es) Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
BRPI0807487A8 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
BR122020006906B8 (pt) compostos e composições farmacêuticas antivirais
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
CL2011001215A1 (es) Compuestos derivados de pirimidina, inhibidores de tirosina quinasa; composiciones farmaceuticas que los comprenden; y su uso en el tratamiento y/o prevencion de cancer, enfermedades inflamatorias y enfermedades autoinmunes.
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
ECSP11011054A (es) Péptidos antivirales terapéuticos
HN2006029142A (es) Proceso
CL2008001728A1 (es) Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de cancer, infecciones, enfermedades inflamatorias y autoinmunes.
SV2006002290A (es) Nonadepsipeptidos acilados ii ref. bhc041327-sv